跳至主要内容
临床试验/jRCT2080225272
jRCT2080225272已完成2 期

Observational study of routine ophthalmological examinations of patients included in the 2 Bayer sponsored phase 3 clinical trials FIDELIO and

Bayer Yakuhin, Ltd1 个研究点目标入组 800 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
800
试验地点
1
主要终点
Progression of non-proliferative diabetic retinopathy (NPDR)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20age old over 至 No limit(—)
性别
All

入选标准

  • Inclusion Criteria:
  • Signed informed consent to participate in ReFineDR
  • Included in FIDELIO or FIGARO, and with DR as medical history
  • Documented NPDR in at least one eye, as documented by ophthalmological records within 6 months prior to baseline in FIDELIO or FIGARO, and up to one month after baseline in FIDELIO or FIGARO
  • An ophthalmological assessment available 6 month before or maximum 1 month after the baseline examination in FIDELIO or FIGARO, and at least one additional assessment afterwards.

排除标准

  • Exclusion Criteria:
  • Patients with PDR, macular edema or anterior segment complications present at baseline in FIDELIO or FIGARO in at least one eye.
  • Patients with any documentation of prior or planned retinal laser treatment, intravitreal injection or vitrectomy at baseline in FIDELIO or FIGARO in at least one eye.
  • Patients with any other retinal disease documented at baseline in FIDELIO or FIGARO in at least one eye that would likely interfere with the study objectives (e.g. neovascular age-related macular degeneration or retinal vein occlusion).

结局指标

主要结局

Progression of non-proliferative diabetic retinopathy (NPDR)

时间窗: after start of treatment until end of Year 2

Progression of non-proliferative diabetic retinopathy (NPDR) defined by the occurrence of vision-threatening events i.e. proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), anterior segment neovascularization (ASN)

次要结局

  • Progression of NPDR(until end of Year 1 and until the end of Year 2 after start of treatment)

研究者

发起方
Bayer Yakuhin, Ltd

研究点 (1)

Loading locations...

相似试验